decitabine,venetoclax
MGI Pharma,SuperGen,roche,abbvie
['decitabine', 'deter,(-determin),(-deterio)', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax']
#ash22 #leusm othman: n=55 evaluated by npm1 qpcr (assessments at the discretion of treating doc), 55% hma, 45% ldac. undetectable mrd achieved in 46%, &gt;4 log reduction but detachable 19%. no diff seen between hma vs ldac. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)